- Syneron Medical (NASDAQ:ELOS +0.7%) Q1 results: Revenues: $63.4M (+11.6%); COGS: $30.7M (+12.0%); R&D Expense: $5.7M (-8.1%); SG&A: $28.3M (+19.9%); Operating Loss: ($1.4M) (-75.0%); Net Loss: ($1.5M) (-36.4%); Loss Per Share: ($0.04) (-33.3%); Quick Assets: $83M (-11.4%); CF Ops: ($5.6m) (-19.1%).
- No guidance given.